GLP-1 (7-37) Peptide API

GLP-1 (7-37) Peptide API CAS 106612-94-6 | Native Incretin Peptide Manufacturer for Research

Core Selling Points

✓ ≥98% HPLC Purity

✓ LC-MS Full Sequence Verification

✓ Batch-Specific COA Available

✓ GMP-Aligned Production System

✓ Global Export Regulatory Support

✓ Custom Peptide Synthesis Service

GLP-1 (7-37) peptide API is a major biologically active endogenous fragment of glucagon-like peptide-1, categorized as a native bioactive GLP-1 receptor ligand, not a synthetic analogue. Compared with GLP-1 (7-36) amide, this full-length native fragment presents complete physiological sequences and plays a core role in glucose metabolism regulation, insulin secretion modulation and gastrointestinal tract physiological research. This peptide material is widely used for native GLP-1 baseline mechanism exploration, metabolic disorder research and preclinical peptide drug evaluation.

Produced via optimized Fmoc solid-phase peptide synthesis and multi-stage gradient HPLC purification, our GLP-1 (7-37) peptide API retains complete native amino acid sequence, stable biological activity and excellent batch-to-batch consistency. The product is strictly for laboratory and pharmaceutical R&D use only, not for direct clinical administration.

Every production batch of GLP-1 (7-37) undergoes dual strict QC testing (HPLC + LC-MS) in HDM BIO's in-house analytical laboratory, ensuring full native structure integrity and high purity for academic and pharmaceutical R&D.

When sourcing GLP-1 (7-37) peptide API for metabolic pharmacological research, laboratories and procurement teams must verify core quality standards to avoid truncated fragments and invalid active impurities:

1. Native sequence verification: Confirm full-length GLP-1 (7-37) complete sequence via LC-MS to ensure no missing amino acid impurities

2. Purity validation: Verify ≥98% HPLC purity and complete impurity profile for accurate physiological research data

3. Batch documentation: Obtain exclusive batch COA, HPLC chromatogram and full production traceability records

4. Long-chain peptide manufacturing capacity: Confirm mature SPPS technology for stable long native peptide synthesis

5. Export compliance: Complete regulatory documents and technical support for global laboratory procurement

GLP-1 (7-37) is a long-chain linear native GLP-1 bioactive fragment with high synthetic technical barriers. Long-chain sequential amino acid coupling is prone to deletion impurities, which directly affect the integrity of native physiological activity and receptor binding efficiency.

Core manufacturing difficulties include precise stepwise coupling control, effective removal of truncated peptide by-products, and full protection of native peptide activity during purification and lyophilization. HDM BIO adopts optimized long-chain SPPS process and multi-stage high-precision HPLC purification, with each batch fully verified by LC-MS to ensure complete native sequence and stable batch consistency.

GLP-1 (7-37) peptide API is a full-length native endogenous GLP-1 fragment, activating GLP-1 receptors to regulate physiological glucose metabolism, widely used for native GLP-1 baseline mechanism and metabolic pharmacology research.

As the primary native ligand of human GLP-1 receptor, GLP-1 (7-37) participates in glucose-dependent insulin secretion, glucagon inhibition and gastric emptying regulation. It serves as the gold-standard control material for distinguishing native GLP-1 physiological effects from synthetic GLP-1 analogues in preclinical drug research.

Native full-length GLP-1 fragments and artificially modified GLP-1 analogues differ significantly in structural origin, half-life and research scenarios, providing differentiated values for metabolic research:

Native GLP-1 fragments and synthetic GLP-1 agonists have distinct structural and functional characteristics, supporting multi-dimensional metabolic research.

Explore our complete GLP-1 peptide API portfolio: GLP-1 (7-37), GLP-1 (7-36) amide, Exenatide, Liraglutide, Semaglutide, Tirzepatide for systematic metabolic peptide research solutions.

GLP-1 (7-37) peptide API is produced via optimized Fmoc solid-phase peptide synthesis, multi-stage precision impurity separation and vacuum lyophilization, ensuring complete native sequence and stable biological activity for high-standard pharmaceutical R&D.

Production Workflow

Raw Material Inspection → Fmoc SPPS Sequential Coupling → Resin Cleavage → Multi-stage HPLC Purification → Vacuum Lyophilization → QC Testing → Batch COA Issuance → Sealed Light-Proof Pharmaceutical Packaging

QC Inspection Workflow

Incoming Raw Material QC → In-process Long-Chain Coupling Monitoring → HPLC Purity Testing → Mass Spectrometry Identity & Sequence Verification → Moisture & Heavy Metal Testing → Residual Solvent Detection → Final Batch Release Approval

Core Process Highlights

- Optimized long-chain coupling technology minimizes truncated peptide impurities and protects native bioactivity - Multi-gradient HPLC purification thoroughly removes structural analog impurities to guarantee batch consistency

Long-chain native GLP-1 fragment synthesis has high technical barriers. Professional suppliers must meet the following core standards:

1. Professional long peptide synthesis capability: Mature SPPS technology for full-length native GLP-1 fragment production

2. Dual QC verification system: Batch HPLC purity + LC-MS full sequence confirmation

3. Standard quality system: GMP-aligned production with ISO & HACCP certification

4. Complete traceability: Full batch production records and exclusive COA documents

5. Global export support: Complete compliance documents for international laboratory procurement

HDM BIO provides stable high-quality GLP-1 (7-37) peptide API supply with integrated synthesis, purification and professional technical testing services.

The bulk price of GLP-1 (7-37) peptide API is affected by multiple R&D procurement factors:

- Purity specification: Custom ≥99% high-purity grade increases production difficulty and cost

- Order volume: Bulk orders enjoy tiered discount pricing

- Custom testing service: Third-party certification or full sequence mapping raises quotation standards

- Customized processing: Special packaging or stability modification requirements affect final cost

- Logistics scheme: Cold-chain transportation for activity protection adds delivery cost

HDM BIO provides flexible sample, small-batch and large-batch supply solutions. Contact the sales team to obtain the latest customized bulk quotation.

- 10+ years of professional native GLP-1 series peptide API manufacturing experience in China

- ISO & HACCP certified quality system with GMP-aligned production workshops

- Strict LC-MS native sequence verification and full production traceability per batch

- Flexible supply from lab trial samples to large-scale industrial bulk orders

Q: Where can I buy GLP-1 (7-37) peptide API in China?

A: HDM BIO is a professional China-based native GLP-1 peptide manufacturer, providing high-purity GLP-1 (7-37) peptide API for global pharmaceutical and biotech R&D institutions with complete export documents.

Q: What is the difference between GLP-1 (7-37) and GLP-1 (7-36) amide?

A: GLP-1 (7-37) is a full-length native endogenous fragment, while GLP-1 (7-36) amide is a truncated active isoform; both are native peptides and not synthetic analogues, used for comparative physiological mechanism research.

Q: How is GLP-1 (7-37) peptide API quality verified?

A: Each batch is verified by HPLC purity detection and LC-MS full sequence identification to ensure complete native peptide structure and no invalid impurities.

Q: What is the CAS number of GLP-1 (7-37)?

A: The CAS registry number of GLP-1 (7-37) is 106612-94-6.

Q: Is GLP-1 (7-37) a native peptide or GLP-1 analogue?

A: GLP-1 (7-37) is a full-length native bioactive GLP-1 fragment, not a synthetic GLP-1 analogue, suitable for original physiological mechanism research.

Q: What purity grades are available for GLP-1 (7-37) peptide API?

A: We provide standard ≥98% HPLC research grade and customized ≥99% high-purity grade for high-standard preclinical research.

Q: How to store GLP-1 (7-37) lyophilized peptide powder?

A: Store sealed at -20°C, protected from light and moisture, and avoid repeated freeze-thaw cycles to retain biological activity.

Written by: HDM BIO Pharmaceutical Peptide Technical Content Team Specialized in peptide API industry analysis, metabolic pharmacology R&D applications and GMP manufacturing standards.

Reviewed by:

- HDM BIO Peptide Chemistry Team

- HDM BIO Quality Assurance Department

- HDM BIO Analytical Testing Laboratory

Review Scope: Native GLP-1 long-chain peptide synthesis pathway, purification compliance, HPLC & MS analytical method validity, GMP-aligned production control requirements.

Last Updated: August 2026

We provide full one-stop support for global pharmaceutical enterprises, research institutions and biological laboratories sourcing GLP-1 (7-37) peptide API:

• Batch-specific COA
• MSDS Safety Data Sheet
• GMP & ISO Certification Documents
• Custom Bulk Wholesale Pricing
• Free Samples Available
• Dedicated Technical Formulation Support

Request COA Get Bulk Pricing Request Sample

WhatsApp: +86 19991242181

Email: sales@hdmbio.com

Hot Tags: glp-1 (7-37) peptide api, China glp-1 (7-37) peptide api manufacturers, suppliers, factory, 17α-Estradiol, api, Dienogest Powder, Estradiol Undecylate Powder, Estriol Powder, Fezolinetant Powder